Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Exemestane
Sponsor: Pfizer